Key hormones released by EECs include GLP-1, GIP, cholecystokinin (CCK), ghrelin, and peptide YY (PYY)
While the active ingredient is the same molecule used in brand-name formulations, the manufacturing process, quality control, potency verification, and sterility assurance differ significantly
Retatrutide for the treatment of obesity, obstructive sleep apnea and other conditions (TRIUMPH programme)
As a result, some patients notice a metallic or unusual flavour, especially in the early weeks or after a dose increase
What is consistent is the message for patients: these are effective medications with substantial benefits, and the sensible course is informed monitoring rather than avoidance